Study of Amritadi churna in rheumatoid arthritis.

Etiopathological study of aamvata and therapeutical evaluation of amritadi churna in the management of aamvata (Rheumatoid Arthritis)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051316

Enrollment

Registered

2023-04-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: prediagnosed and confirmed patients of aamavata with chronicity of less than 6 years

Exclusion criteria

Exclusion criteria: Patients below 20 years and above 65 years of age. chronicity more than 6 years. Patients having neoplasm of spine, gout, anchylosing spondylitis, traumatic arthritis and pyogenic osteomyelitis etc.

Design outcomes

Primary

Measure	Time frame
Assessment of RA FactorTimepoint: 60 days	—

Secondary

Measure	Time frame
RA factorTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Brahmanand Sharma

University Post Graduate Institute of Ayurveda studies and research,

bkmudgal9@gmail.com9460318138

Outcome results